Pagnotta E
ORCID: 0000-0002-9477-1724
· 1 paper in corpus
Most therapies used in patients affected by inflammatory bowel diseases are ineffective in preventing the development of chronic visceral hypersensitivity, mainly due to inflammation-induced enteric neuroplasticity. Glucosinolates, secondar…